Aime S, Bergamasco B, Casu M et al (2000) Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson’s disease. Mov Disord 15:977–981. https://doi.org/10.1002/1531-8257(200009)15:5%3c977::aid-mds1032%3e3.0.co;2-q

Article  CAS  PubMed  Google Scholar 

Barrett PJ, Timothy Greenamyre J (2015) Post-translational modification of α-synuclein in Parkinson’s disease. Brain Res 1628:247–253. https://doi.org/10.1016/j.brainres.2015.06.002

Article  CAS  PubMed  Google Scholar 

Bergsland N, Zivadinov R, Schweser F et al (2019) Ventral posterior substantia nigra iron increases over 3 years in Parkinson’s disease. Mov Disord 34:1006–1013. https://doi.org/10.1002/mds.27730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bharathi null, Indi SS, Rao KSJ, (2007) Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study. Neurosci Lett 424:78–82. https://doi.org/10.1016/j.neulet.2007.06.052

Article  CAS  Google Scholar 

Bi M, Du X, Jiao Q et al (2020) α-Synuclein regulates iron homeostasis via preventing parkin-mediated DMT1 ubiquitylation in Parkinson’s disease models. ACS Chem Neurosci 11:1682–1691. https://doi.org/10.1021/acschemneuro.0c00196

Article  CAS  PubMed  Google Scholar 

Biondetti E, Santin MD, Valabrègue R et al (2021) The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease. Brain 144:3114–3125. https://doi.org/10.1093/brain/awab191

Article  PubMed  PubMed Central  Google Scholar 

Brammerloh M, Morawski M, Friedrich I et al (2021) Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry. Neuroimage 239:118255. https://doi.org/10.1016/j.neuroimage.2021.118255

Article  CAS  PubMed  Google Scholar 

Buijs M, Doan NT, van Rooden S et al (2017) In vivo assessment of iron content of the cerebral cortex in healthy aging using 7-Tesla T2*-weighted phase imaging. Neurobiol Aging 53:20–26. https://doi.org/10.1016/j.neurobiolaging.2016.09.005

Article  CAS  PubMed  Google Scholar 

Cabantchik ZI, Munnich A, Youdim MB, Devos D (2013) Regional siderosis: a new challenge for iron chelation therapy. Front Pharmacol 4:167. https://doi.org/10.3389/fphar.2013.00167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Q, Huang J, Tang D et al (2022) Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson’s disease. Front Neurol 13:1096966. https://doi.org/10.3389/fneur.2022.1096966

Article  PubMed  Google Scholar 

Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson’s disease. Acta Neuropathol 100:111–114. https://doi.org/10.1007/s004010050001

Article  CAS  PubMed  Google Scholar 

Chen K, Zhang L, Mao H et al (2023) The impact of iron deposition on the fear circuit of the brain in patients with Parkinson’s disease and anxiety. Front Aging Neurosci 15:1116516. https://doi.org/10.3389/fnagi.2023.1116516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Q, Huang J, Liang J et al (2020) Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson’s disease using quantitative susceptibility mapping and R2* mapping. Exp Ther Med 19:3778–3786. https://doi.org/10.3892/etm.2020.8645

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cosottini M, Donatelli G, Ricca I et al (2022) Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases. Eur Radiol 32:8058–8064. https://doi.org/10.1007/s00330-022-08865-6

Article  CAS  PubMed  Google Scholar 

Costa-Mallen P, Zabetian CP, Agarwal P et al (2015) Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism Relat Disord 21:1087–1092. https://doi.org/10.1016/j.parkreldis.2015.07.006

Article  PubMed  PubMed Central  Google Scholar 

Costa-Mallen P, Gatenby C, Friend S et al (2017) Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease. J Neurol Sci 378:38–44. https://doi.org/10.1016/j.jns.2017.04.035

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dashtipour K, Liu M, Kani C et al (2015) Iron accumulation is not homogenous among patients with Parkinson’s Disease. Parkinsons Dis 2015:324843. https://doi.org/10.1155/2015/324843

Article  PubMed  PubMed Central  Google Scholar 

Dekens DW, Eisel ULM, Gouweleeuw L et al (2021) Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases. Ageing Res Rev 70:101414. https://doi.org/10.1016/j.arr.2021.101414

Article  CAS  PubMed  Google Scholar 

Depierreux F, Parmentier E, Mackels L et al (2021) Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. NPJ Parkinsons Dis 7:57. https://doi.org/10.1038/s41531-021-00199-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desai Bradaric B, Patel A, Schneider JA et al (2012) Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (vienna) 119:59–71. https://doi.org/10.1007/s00702-011-0684-8

Article  PubMed  Google Scholar 

Devos D, Moreau C, Devedjian JC et al (2014) Targeting chelatable iron as a therapeutic modality in Parkinson’s disease. Antioxid Redox Signal 21:195–210. https://doi.org/10.1089/ars.2013.5593

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devos D, Labreuche J, Rascol O et al (2022) Trial of deferiprone in Parkinson’s disease. N Engl J Med 387:2045–2055. https://doi.org/10.1056/NEJMoa2209254

Article  CAS  PubMed  Google Scholar 

Dexter DT, Wells FR, Agid F et al (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet 2:1219–1220. https://doi.org/10.1016/s0140-6736(87)91361-4

Article  CAS  PubMed  Google Scholar 

Dexter DT, Carayon A, Javoy-Agid F et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953–1975. https://doi.org/10.1093/brain/114.4.1953

Article  PubMed  Google Scholar 

Du G, Lewis MM, Sica C et al (2018) Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson’s patients. Mov Disord 33:1423–1431. https://doi.org/10.1002/mds.27318

Article  PubMed  PubMed Central  Google Scholar 

Du G, Wang E, Sica C et al (2022) Dynamics of nigral iron accumulation in Parkinson’s disease: from diagnosis to late stage. Mov Disord 37:1654–1662. https://doi.org/10.1002/mds.29062

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dusek P, Hofer T, Alexander J et al (2022) Cerebral Iron Deposition in Neurodegeneration. Biomolecules 12:714. https://doi.org/10.3390/biom12050714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Febbraro F, Giorgi M, Caldarola S et al (2012) α-Synuclein expression is modulated at the translational level by iron. NeuroReport 23:576–580. https://doi.org/10.1097/WNR.0b013e328354a1f0

Article  CAS  PubMed  Google Scholar 

Fischbacher A, von Sonntag C, Schmidt TC (2017) Hydroxyl radical yields in the Fenton process under various pH, ligand concentrations and hydrogen peroxide/Fe(II) ratios. Chemosphere 182:738–744. https://doi.org/10.1016/j.chemosphere.2017.05.039

Article  ADS  CAS  PubMed  Google Scholar 

Foroutan P, Murray ME, Fujioka S et al (2013) Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus. Radiology 266:280–288. https://doi.org/10.1148/radiol.12102273

Article  PubMed  PubMed Central  Google Scholar 

Friedlich AL, Tanzi RE, Rogers JT (2007) The 5’-untranslated region of Parkinson’s disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry 12:222–223. https://doi.org/10.1038/sj.mp.4001937

Article  CAS  PubMed  Google Scholar 

Friedman A, Galazka-Friedman J (2012) The history of the research of iron in Parkinsonian substantia nigra. J Neural Transm (vienna) 119:1507–1510. https://doi.org/10.1007/s00702-012-0894-8

Article  CAS  PubMed  Google Scholar 

Fu X, Deng W, Cui X et al (2021) Time-specific pattern of iron deposition in different regions in Parkinson’s disease measured by quantitative susceptibility mapping. Front Neurol 12:631210. https://doi.org/10.3389/fneur.2021.631210

Article